Allergy Therapeutics plc is a United Kingdom-based commercial biotechnology company. The Company is focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines. Its segments include Central Europe, which include segments, such as Germany, Austria, Switzerland and the Netherlands; Southern Europe, which includes Italy, Spain and Other; the United Kingdom, and Rest of World. It sells both injectable and sublingual allergen-specific immunotherapies. Its pipeline candidates include Grass MATA MPL, Birch MATA MPL, Ragweed MATA MPL, Trees MATA MPL and Peanut SCIT. Its vaccine candidates outside allergy include disease areas, including cancer, asthma, atopic dermatitis and psoriasis. Its products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Venomil, VLP Peanut and ImmunoBON.

• Revenue in GBP (TTM)79.00m
• Net income in GBP-5.38m
• Incorporated2004
• Employees601.00

• Location
  Allergy Therapeutics PLCDominion WayWORTHING BN14 8SAUnited KingdomGBR
• Phone+44 190 384 4700
• Fax+44 190 384 4726
• Websitehttp://www.allergytherapeutics.com/